- Select a blog category
In our recent report Vital Signs: How to deliver better healthcare across Europe, patient engagement and empowerment is included as one of the seven vital signs of a high performing health system.i During my placement with the Deloitte Centre for Health Solutions, I worked on the final stages of this report publication. One of the quotes from the report that resonates most with me is “If patient engagement were a drug it would be the blockbuster drug of the century and malpractice not to use it”.ii Indeed it reminded me of an incident that occurred last year while I was practicing as an adult psychiatrist and psychotherapist in Germany. In sharing this story I hope to demonstrate why patient engagement matters.
I am delighted to use this week’s blog to introduce one of the Centre’s new analysts, Amen Sanghera. During his MSc studies in Nanotechnology and Regenerative Medicine (2013 -14) Amen was fortunate to gain first-hand exposure to the potential that precision medicine (PM) can have for patients. His blog explores this potential and considers the extent to which key stakeholders (payers, providers, physicians and patients) are ready to embrace the move towards precision medicine.
The UK Sepsis Trust and ‘Starfish’ a powerful story of a sepsis survivor: why raising awareness is key to saving 14,000 lives each year
This week I was privileged to attend a reception at Deloitte introducing a new feature film ‘Starfish’i hosted together with the UK Sepsis Trust. The film is based on the experience of Tom Ray who survived sepsis. This week’s blog features an article written by Dr Ron Daniels BEM, CEO of the UK Sepsis Trust and a global expert on sepsis, together with Tom Ray who recounts his first-hand experience of recovering from the devastating consequences of sepsis.
Can partnerships between industry, providers and academia deliver health systems that are fit for the future?
Our recent report, Vital Signs - How to deliver better healthcare across Europe, set out to explore how six European countries – Denmark, France, Germany, Netherlands, Spain and the UK – are tackling the common challenges that they face. We identified that one of the vital signs of a strong health economy is partnership working between healthcare providers, academia and industry. This week’s blog explores what needs to be in place to create effective partnerships and deliver high quality healthcare. The blog first appeared in Scripi and is the second in a series of exclusive columns that Deloitte is providing to Scrip, and which we agreed we would subsequently share with our own readers.
Over the past few weeks the realities of the financial challenges facing the NHS have become increasingly evident. Analysis by the Nuffield Trust estimates that hospitals will have to achieve twice the level of efficiencies achieved in recent years, to have any hope of closing the £22 billion funding gap by 2020. Furthermore, that without extra funding or unprecedented savings and a steep reduction in patient demand, major cuts in services are inevitable. Evidence is already emerging that treatment waiting times are increasing and rationing is becoming more pervasive.i This week’s blog considers one example of this rationing, cataract surgery, the leading case of reversible blindness and visual impairment worldwide. This issue resonates personally with me, as I saw first-hand the distressing impact that this condition can have on a loved one.
In our recent report Vital Signs: How to deliver better healthcare across Europe, one of the vital signs was hospital productivity which highlighted the importance of standardised systems and processes, technology and new ways of working. This week’s blog discusses how one hospital group in the United States (US) standardised its clinical processes across multiple sites to improve efficiency and productivity. This is the second in a series of contributions from Dr Bob, a partner in our health consulting business on secondment from the US who has spent 20 years as a practicing physician in the US, followed by 20 years as a healthcare consultant working with numerous health systems.
This week we’re delighted to feature an article written by our US colleague Terri Cooper, PhD, Principal and the Federal Health Sector Leader, Deloitte Consulting, LLP on a subject that is personal to us all. Most of us will know of someone, a friend, colleague or family member that cancer has impacted. While the Cancer Moonshot is a US led initiative, the outcomes should, in time, benefit us all in our fight against cancer.
The NHS may have survived financial scrutiny in 2015-16 but how sustainable is the current funding model?
The financial challenges facing the NHS have been a keen focus of policy and media commentators for much of 2015-16. However, until last week, a key question on many people’s minds was whether the Department of Health (Department) and the NHS would exceed their 2015 -16 agreed expenditure limits and, if so, the impact of this on 2016-17 spending. In the event, the publication of the National Audit Office (NAO) reports on the audited accounts of the Department, NHS England and NHS Foundation Trusts’ consolidated accounts 2015-16, provides the definitive view.i This week’s blog explores the key findings from the NAO’s scrutiny of NHS spending in 2015-16 and the implications for the future sustainability of the NHS in the face of continuing increases in demand and constrained funding.
Last week we published our report ‘Vital Signs: How to deliver better healthcare across Europe’, which focussed predominantly on what good care might look like. The report highlights three common enablers across all seven vital signs intended to help transform healthcare services: standardising systems and processes, workforce working differently and the adoption of health technology. This week’s blog provides deeper insight into the Partnership Vital Sign, with a focus on the benefits that can be derived from building successful digital partnerships between life sciences and technology companies. This blog, authored by Roland Foxcroft one of our Monitor Deloitte colleagues, appeared in Scripi and is the first in a series of exclusive columns that Deloitte is providing to Scrip, and which we agreed we would subsequently share with our readers.
Health systems in Europe are diverse, the result of history, culture and the economic and political environment in which they operate. They range from predominantly single-payer systems, such as the UK and Spain, which tend to spend a lower amount of their resources (Gross Domestic Product (GDP)) on healthcare; to systems of competing insurers and providers such as Germany and the Netherlands, which are two of Europe’s highest spenders on healthcare. Understanding what makes an effective healthcare system is therefore quite challenging. This week’s blog summarises the findings in our new report, Vital Signs- How to deliver better healthcare across Europe.
Digital technology is helping to transform the way citizens interact with service providers across all service industries. The time is now ripe for changing the relationship between health and social care commissioners and providers and service users. This week’s Thought from the Centre blog brings you the views of our lead partner for social services on the need for an increased focus on digital transformation across health and social care through the adoption of a more ‘digital mindset’.